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Abstract.  The integrin family of adhesion receptors 
consists of several heterodimeric glycoproteins, each 
composed of one a  and one/3 subunit.  A novel inte- 
grin ot subunit partial cDNA isolated from TGF-/3 
stimulated guinea pig airway epithelial cells has previ- 
ously been reported (Erie,  D. J., D.  Sheppard,  J. 
Bruess, C.  Riiegg,  and R. Pytela.  1991. Am. J. Respir. 
Cell Mol.  Biol.  5:170-177).  We have now determined 
cDNA and amino acid sequence for the human homo- 
log of this subunit,  named or9, from a human lung 
eDNA library,  a human small intestine cDNA library, 
and cDNA from the cell lines U937, HL-60 and 
Tera-2.  This sequence is predicted to encode a  1006- 
amino acid mature protein that shares 39%  identity 
with the previously identified integrin subunit a4.  By 
Northern blot analysis,  or9 mRNA was detected in the 
human carcinoma cell lines Tera-2 and Caco-2. 
Anti-peptide antibodies against the predicted COOH- 
terminal  sequence of o~9 immunoprecipitated a hetero- 
dimer (140 kD/ll5 kD nonreduced;  150 kD/130 kD 
reduced) from Tera-2 lysates. Immunodepletion of/31- 
containing  integrins  with Tera-2 lysates removed oD 
immunoreactivity,  suggesting that/31  is the principal fl 
subunit partner for or9 in these cells,  t~9 was detected 
by immunohistochemistry in airway epithelium,  in the 
basal layer of squamous epithelium,  and in smooth 
muscle, skeletal muscle, and hepatocytes. 
T 
hE integrins  are a large family of cell surface glyco- 
proteins that mediate cell-cell and cell-matrix adhe- 
sion (21). All known members of this family are bet- 
erodimers consisting  of an c~ and a 13 subunit that bind non- 
covalently to each other. Published reports suggest the exis- 
tence of 8/3 subunits (/31-/38) (2, 12, 14, 20, 26, 30, 32, 34, 
37, 40, 41) and 16 c~ subunits (2-5, 9, 10, 13, 16, 23, 25, 28, 
33,  38,  39, 42-47).  13 of these have been completely se- 
quenced (a 1-or8, c~v, c~M, ctL, aX, txIIb). The existence of 
aIEL and otLRI has been established on the protein level. 
We have previously reported identification of partial integrin 
a  subunit cDNA sequences using  degenerate  oligonucleo- 
tide primer pairs and the PCR (13). Primers were designed 
based on two highly  conserved regions,  separated  by 72- 
92-amino acid residues,  located within  the fifth and sixth 
repeated  domains  of the  previously  reported  integrin  ot 
subunits.  PCR amplification  of eDNA using these primers 
resulted in the identification  of several  integrin  a  subunit 
partial  cDNAs. From guinea pig airway epithelial  cells six 
different sequences were identified.  Five of these were 88 to 
92% identical  to the sequences of cd-ot3, a5 and c~v from 
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other species and were presumed to encode the guinea pig 
homologs of those subunlts.  One of the amplified sequences 
was only 24-60%  identical  to previously reported tx sub- 
units. This novel eDNA was predicted to encode a 71-amino 
acid fragment of an integrin  t~ subunit,  provisionally  desig- 
nated aA. We now report the predicted coding sequence of 
the human homolog of this novel subunit. We have identified 
mRNA encoding this subunlt and the corresponding protein 
in two cell lines,  including  the human  teratoma  cell line 
Tera-2, and demonstrate that this ot subunit associates prin- 
cipally with the integrin/31  subunit in these cells. Based on 
the convention  of sequentially  numbering newly identified 
partners of 131, we have called this ct subunit  a9.  We also 
demonstrate wide distribution  of or9 in epithelia,  smooth 
muscle, skeletal  muscle,  and hepatocytes. 
Materials and Methods 
Cell Lines, RNA Purification,  and cDNA Synthesis 
ATCC human cell lines were maintained in DME (HeLa, Tera-2, Caco-2,) 
or RPMI  1640 media (U937, HL-60,  Raji,  HuT 78,  MOLT-4) contain- 
ing  10%  FBS. Media were obtained  from BioWhittaker, Inc.  (Waikers- 
ville, MD). 
mRNA was isolated from resected  human  lung tissue using the Fast 
Track mRNA isolation kit (Invitrogen, San Diego, CA). Total cellular RNA 
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synthesized at 44°C for 1 h from 1 to 5/~g of mRNA or 20-40/~g of total 
RNA  using  the  Superscript  cDNA  Synthesis  System  (GIBCO-BRL, 
Galthersburg, MD) and random DNA hexamers. In some cases cDNA was 
synthesized as above using a previously described sequence tagged random 
DNA  hexamer  primer  (CGA~ATGGTCGACGGAAGCGACC- 
NNNNNNT)  (15). 
Amplification and Purification of  Lambda 
Library DNA 
Aliquots of Xgtl 1 libraries containing 1-5 million plaque forming units were 
mixed with 500 #1 of LE392 bacteria (OD  =  0.5) in SM buffer (100 mM 
NaC1, 8 mM MgSO4, 50 mM Tris-HC1, pH 7.0, 0.01% gelatin), incubated 
15 rain at 37°C, and shaken at 250 rpm overnight at 37°C in Luria broth 
containing 10 mM MgC12 and 0.2% maltose. The cultures were incubated 
at 37°C and 250 rpm for 30 min with 5% chloroform. Aliquots of the aque- 
ous layer were subjected to three cycles of 3 min in dry ice/ethanol followed 
by 3  rain at 90°C,  phenol/chloroform extraction,  and precipitation with 
ethanol. 
PCR Amplification 
PCR reactions were performed in 25-200/~1 reaction volumes and con- 
rained  1  ×  Taq  buffer  (Promega,  Corp.,  Madison,  WI)  with  1.5  mM 
MgCI2, 0.1/~M each of two primers, 0.025 U/pl Taq Polymerase (Promega 
Corp.),  1-8/~1 of DNA template, and 0.1 mM each of dATP, dGTP, dCTE 
and dTTP.  Reactions were heated to 94°C  for 4  rain in a  thermocycler 
(ElUCOMP, Inc., San Diego, CA) and then subjected to 30 cycles of PCR fol- 
lowed by 10 rain at 72°C. Reactions that contained degenerate oligonncleo- 
tide primers were subjected to PCR cycles consisting of 45 s at 94°C, 45 s 
at 48 or 53 °C, and 45 s at 72°C. Reactions that contained cO-specific primer 
pairs designed to amplify DNA fragments less than 750 nucleotides were 
subjected to PCR cycles consisting of 45 s at 94°C, 45 s at 57°C, and 60 s 
at 72°C.  Reactions that contained an cO-specific primer, a Xgtll-specific 
primer CAgtllF: CCTCCGTCGA~GGTGC~GACGACTC~CCG  or 
~tlLR:  CCTCCGTC~~CAACTGGTAATG),  and puri- 
fied concentrated total library DNA were subjected to PCR cycles consist- 
ing of 45 s at 94°C, 45 s at 60°C, and 120 s at 72°C. All other PCR reactions 
were subjected to cycles consisting of 45 s at 94°C, 45 s at 570C, and 120 s 
at 72°C. Products of each PCR reaction were analyzed by agarose gel elec- 
trophoresis using standard or low gel temperature agarose. 
PCR reactions designed to amplify 3' sequence from sequence tagged 
cDNA,  described  above,  contained  r,9-specific  forward  primers  and 
primers complementary to the sequence tagged random hexamer (GAT- 
GGTCGACGGAAGCGAAC or CGA~ATGGTCGACGG)  and were 
performed as above. 
Cloning of DNA Fragments 
Restriction-digested DNA fragments were isolated on low gel temperature 
agarose and purified by phenol/chloroform extraction and ethanol precipita- 
tion.  Fragments were ligated into restriction-digested,  dephosphorylated 
pBluescript vector (Stratagene, La Joila, CA) with T4 DNA ligase (GIBCO- 
BRL). The ligation mixture was used to transform competent Escherichia 
coli (JM-109; Clontech, Palo Alto, CA). Selected plasmids were purified 
from liquid cultures using the Pharmacia miniprep lysis kit (Pharmacia Fine 
Chemicals/LKB,  Pleasant Hill,  CA) and sequenced using Sequenase 2.0 
(United  States  Biochemical  Corporation,  Cleveland,  OH),  35S-dATP 
(Amersham Corp., Arlington Heights, IL), T3 primer, T7 primer, and a 
variety of primers specific for c~9. 
Library Screening 
Partial cDNA fragments were used as templates for the random-primed syn- 
thesis  of  [32p]dCTP-labeled  probes  (multiprime  DNA  labeling  system; 
Amersham Corp.).  These probes were used to screen an oligo-dT-primed 
Xgtl I cDNA library from human lung tissue including trachea and bronchi- 
oles (catalog No. HL 1066b; Clontech) and a mixed random and oligo-dT 
primed Xgtll cDNA library from human small intestine tissue (catalog No. 
HLlI33b; Clontech). Hybridizations were performed at 50°C for 16 h in 
hybridization buffer (40% formamide, 50 mM sodium phosphate, pH 6.5, 
800 mM  NaCI,  0.05%  polyvinylpyrrolidone,  0.05%  BSA, 0.05%  ficoll, 
1 mM EDTA, 0.1%  SDS, and 10 ng/mi heat-denatured, sonicated salmon 
sperm DNA). Filters were washed twice in 1x SSC containing 0.1% SDS 
for 5 min at room temperature, and once in 0.5× SSC containing 0.1% SDS 
for 1 h at 50°C and exposed to film for 18 h at -80°C with intensifying 
screens. Positive library clones were isolated by further rounds of screen- 
ing, and the inserts were isolated either by PCR amplification using ~gtll- 
specific primers or by EcoRI digestion of purified phage DNA. The inserts 
were then subcloned into EcoRI-digested pBluescript and sequenced. 
Northern Blot Analysis 
Total cellular RNA was electrophoresed through a formamide-agarose gel 
and transferred to a nylon membrane (Hybond-N; Amersham Corp.). Ra- 
diolabeled probe was synthesized from 2.1 kb of CO sequence using the Mni- 
tiprime Labeling System (Amersham Corp.) and [32p]dCTP.  Filters were 
incubated at 50°C for 16 h in hybridization buffer containing 5 ×  SSC, 40% 
formamide,  20 mM Tris, pH 7.5,  0.1%  polyvinylpyrrolidone, 0.1%  BSA, 
0.1% flcoll, 10% dextran sulfate, and 100/tg/mi heat-denatured, sonicated 
salmon sperm DNA, and washed in 5x  SSC containing 0.1% SDS at 50°C 
for 30 rain. After washing, filters were exposed to film at -80°C with an 
intensifying screen. 
Antibodies and Immunoprecipitations 
Polyclonal antiserum was generated against the cO peptide CRKENEDSW- 
DWVQKQ.  Peptide synthesis, conjugation to KLH, and injection of rabbits 
was performed by Immunodynamics,  Inc.  (La Jolla, CA).  cO antibodies 
were affinity purified from crude antiserum on a peptide-lysozyme-Affigel 
column as follows.  Affigel-10 slurry (4-ml bed volume) (Bio Pad Labs., 
Richmond, CA) was washed three times with cold 10 mM sodium a~etate, 
pH 4.5; rinsed once with 0.1 M potassium phosphate, pH 7.5; mixed with 
100 rag lysozyme (Sigma Immunochemicals, St. Louis, MO) in 8 ml 0.1 M 
potassium phosphate, pH 7.5,  for 2 h at room temperature; washed twice 
with 0.1 M potassium phosphate, pH 7.5; mixed with 8 ml 0.2 M ethanola- 
mine, pH 8.0, for 2 h at room temperature; and washed three times with 
PBS. Lysozyme-Affigel (600-~1 bed volume) was washed with 0.05 M so- 
dium phosphate, pH 8.0; mixed with 2.5 nag sulfo-m-maleimidobergoyl-N- 
hydmxysuccinimide ester (Pierce Chemicals, Rockford, 1L) in 1 ml 0.05 M 
sodium phosphate, pH 8.0, for 30 min at room temperature; washed with 
0.05 M sodium phosphate; pH 8.0; mixed with 3 mg cO peptide in 500 ~l 
0.05 M sodium phosphate, pH 8.0, for 3 h at room temperature; and washed 
with (a) 0.05 M  sodium phosphate, pH 7.0, (b) 200 mM glycine, pH  1.5, 
(c) 0.05 M sodium phosphate, pH 7.0, (d) 8 M urea, and finally (e) 0.05 M 
sodium phosphate, pH 7.0. 5-10-mi aliquots of antiserum were mixed with 
the peptide-lysozyme-Aitigel overnight at 4°C. The slurry was transferred 
to a column and washed with 0.05 M sodium phosphate, pH 7.0, until the 
OD 280 of the wash buffer was less than 0.01. Antibodies were eluted in 
1.25-mi fractions with 200 mM glycine, pH 1.5, and collected in tubes con- 
taining 250 #l 1 M sodium phosphate, pH 8.0. Pooled fractions were dia- 
lyzed overnight at 4°C against PBS containing 0.02%  azide. 
mAb P5D2 (11) directed against the/31 integrin subunit was a gift from 
Elizabeth  Wayner  (University  of Minnesota,  Minneapolis,  MN).  mAb 
RtCO directed against the 86 integrin subunit was generated in our labo- 
ratory.  For  some  experiments  antibodies  were  cross  linked  to  protein 
A-Sepharose with dimethylpimelimidate (17). 
Cells  were  surface  labeled with  [~25I], lysed  in immunoprecipitation 
buffer (100 mM Tris-HCl, pH 7.5, 0.1% SDS, 1% Triton X-100, 0.1% NP- 
40, and 300 mM NaCl), and immunoprecipitated by standard techniques. 
Samples were analyzed by SDS-PAGE on 7.5%  acrylamide gels and ex- 
posed to film at  -80°C  with intensifying screens. 
~ssue Staining 
Frozen sections (5 ~m) of tissue were fixed in either 2 % paraformaldehyde 
(mouse tissue) at room temperature or in -18°C acetone (human tissue) 
for 5 rain and subsequently rinsed in PBS. Sections were blocked for endog- 
enous pemxidase activity with Peroxoblock Solution (Zymed Laboratories, 
Inc., South San Francisco, CA) for 45 s at room temperature. After rinsing, 
sections were preblocked with 0.5%  casein/0.05% thimerosal/PBS for 15 
rain at room temperature and then incubated overnight at 4°C in primary 
antibody (1:200 in 0.5% casein/0.05% thimemsal/PBS) that either was or 
was not preincubated with 0.1 mg/mi cO peptide for 30 rain at 4°C. After 
rinsing  in  PBS,  sections  were  incubated  in either biotinylated donkey 
anti-rabbit secondary antibody (Amersham Corp.) at a dilution of 1:200 or 
peroxidase-conjngated goat anti-rabbit secondary antibody (Vector Labora- 
tories, Burlingame, CA) at a dilution of 1:250 for 1 h at room temperature 
in 0.5 % casein/0.05 % thimerosal/PBS. Sections incubated with biotinylated 
secondary antibodies were then rinsed and incubated in ABC avidin/pemxi- 
dase reagent (Vector Laboratories) for 1 h at room temperature. Chromagen 
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were monitored until suitable color development was achieved. The signal 
was enhanced with 0.5% nickel chloride, and the sections were rinsed in 
distilled water. Sections were subsequently air dried and then mounted with 
Permount (Fisher Scientific, Pittsburgh,  PA) onto clean slides. 
Protein Sequencing 
Human uterine tissue was homogenized in immunoprecipitation buffer and 
cleared by centrifugation at 200 g.  The supernatant  was incubated with 
afffinity-purified  t~9 anti-cytoplasmic peptide antiserum cross-linked to pro- 
rein A-Sepharose CIAB (Pharrnacia Fine Chemicals, Piscataway, NJ) over- 
night at 40C. The beads were then washed extensively with immunoprecipi- 
tation  buffer  and  heated  to  95"C  for  5  rain  in  2%  SDS, 300  mM 
2-mercaptoethanol, 80 mM Tris, pH 6.8. The supernatant was concentrated 
on a Centricon-10 Concentrator (Amicon, Beverly, MA), subjected to 7.5 % 
SDS-PAGE, transferred to PVDF membrane (Bio Rad Labs. Hercules, CA) 
for 3 h at 50 V in 10 mM 3-(cyclohexylamino)-l-propanesulfonic acid, pH 
11/10% methanol,  and quantified by staining with 0.1% Coomassie blue 
R-250 in 40%  methanol/l%  acetic  acid.  A  prominent  band at  150  kD 
was microsequenced by the USCF Biomedical Resource Center (San Fran- 
cisco, CA). 
Results 
Cloning and Sequencing of Human ~9 
A novel 223-nucleotide partial guinea pig integrin c~ subunit 
cDNA (t~A) was previously reported by Erie et al. (13).  To 
obtain  the  corresponding  human  sequence  of the  novel 
subunit, we used the previously described degenerate inte- 
grin a  subunit forward primer (A14F: CGGAATTCGGIG- 
A(AG)CAG(AC)TIG(CG)I-(GT)CIGA(CT)TT(CT)GG),  a 
degenerate  reverse  primer  based  on  the  t~  sequence 
(AN2R:  CAAGTCGACAA(AG)TGIGC(AG)TT(GC)TA- 
IGCIC(GT)(AG)TC), and eDNA made from human lung tis- 
sue. A band of the predicted size (204 nueleotides) was ob- 
tained (data not shown),  subcloned into pBluescript,  and 
sequenced.  The  resulting  nucleotide  sequence  was  88% 
identical to the sequence of  guinea pig ou~ and 39-54% iden- 
tical to other known human integrin a  subunits. For reasons 
discussed later, we have named this novel human integrin 
subunit or9. 
The  204-nueleotide  or9  cDNA  fragment  was  used  to 
screen a human lung eDNA library. One hybridizing clone, 
L1  (Fig.  1),  was  identified,  purified,  subcloned  and  se- 
quenced. This 1,678-bp clone contained a  1,123-nucleotide 
open reading frame that included the probe sequence. 
We were able to amplify a9 from cDNA from leukocyte 
cell lines  U937  (clones U1-U3) and HL-60 (I41) by PCR 
using ot9-specific primers.  To isolate additional  sequence 
from these cell lines,  we used a  previously described 3'- 
sequence extension technique (15) which employs PCR. One 
clone from HL-60 eDNA,  H2, and one clone from U937 
cDNA, U4, obtained by this method contained 117 nucleo- 
tides of a9 sequence. 
PCR  was  performed on amplified purified human lung 
cDNA library DNA using ot9-specific forward oligonucleo- 
tide primers and hgtl 1-specific primers (hgtl 1F and hgtl 1R). 
Individual bands were isolated, reamplified, subcloned, and 
sequenced. One clone, L2a, consisted of 300 nucleotides of 
~9 sequence. Clone L2a was used as a probe for screening 
the human lung library and one hybridizing clone, L2b, was 
isolated,  purified,  subcloned,  and  sequenced.  Both clone 
L2a and clone L2b ended at nucleotide 1817, suggesting that 
clones L2a and L2b represented the same library clone. 
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Figure L Map of a9 sequencing strategy. Shown are the location 
of clones used to obtain the partial sequence of  human ct9. Internal 
sequence was obtained by use of specific a9 sequencing primers 
(dashes) and by generating restriction fragments at sites shown. 
The clone labeled original PCR clone was obtained from human 
lung eDNA using homology based PCR. Clones labeled L/and L2 
were obtained from a human lung cDNA library. Clones labeled 
U1-U4 were obtained by PCR from U937 eDNA. Clones H/and 
H2 were obtained by PCR from HL-60 eDNA. Clones labeled D1- 
D6 were obtained from a human small intestine eDNA library. 
Clones labeled 77-T3 were obtained by PCR from Tera-2 eDNA. 
The direction and extent of sequencing are indicated with arrows. 
All reported sequence was sequenced completely in both directions 
from at least two independent clones. Noncoding sequences found 
on the 5' end of clones L/(555 bp), D3 (108 bp), and D6 ('~1200 
bp) are not indicated on the map. 
We screened a human duodenal cDNA library with probes 
from clones L1 and L2.  12 independent hybridizing clones 
were identified, isolated,  subcloned, and analyzed. Six of 
these were determined to contain additional or9 cDNA and 
were sequenced (D1-D6). D2 and D6 contained a predicted 
transmembrane domain, cytoplasmic domain, and transla- 
tion stop codon. D6 also had an additional 1.1 kb, 3' of the 
stop codon, which did not extend to the poly(A) tail. 
To complete the or9 sequence,  a9 protein was  purified 
from human uterus using anti-or9 antiserum, described later, 
and  microsequenced.  The  amino  terminal  sequence  was 
equivocally determined to be YNLD(T/P)(Q/E). A series of 
degenerate forward oligonucleotide PCR primers were de- 
signed based upon these possible amino-terminal sequences. 
PCR amplifications were performed using each of the de- 
generate forward primers paired with ot9-specific reverse oli- 
gonucleotide primers and Tera-2 eDNA (data not shown). 
Reactions using a degenerate forward primer based upon the 
sequence YNLDPQ  and two different t~9-specific  reverse 
primers resulted in intense bands which were cloned and se- 
quenced (T1-T3). 
We have sequenced 3,139 nucleotides (Fig. 2) of  a9 eDNA 
that contains a 3,000-nucleotide open reading frame that in- 
cludes a  termination signal  but lacks an initiation codon. 
Based on this cDNA sequence and the amino terminal se- 
quence we obtained, we predict the mature tx9 protein to be 
1,006 amino acids in length with a 947-amino acid extracel- 
lular domain, a 26-amino acid transmembrane domain, and 
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Figure 2.  Human integrin cx9 eDNA sequence and deduced amino 
acid sequence.  The amino acid sequence is shown in one-letter code 
below the first nucleotide  of each codon. The putative transmem- 
brane domain is shown by a double underline.  Asparagine residues 
(N) that are potential sites for N-glycosylation are indicated by dot- 
ted underline.  Conserved putative metal binding domain are indi- 
cated by a single underline.  Nucleotide 36 was determined  to be 
A from some clones and G from others (indicated by a G in paren- 
theses above the nucleotide  location).  Nucleotide 2974 was C in 
some clones and A in others.  None of these nucleotide  variations 
changed the deduced amino acid sequence.  This sequence data is 
available  from EMBL/GenBank/DDBJ  under  accession  number 
L24158. 
a 33-amino acid cytoplasmic domain, o~9 has 12 asparagine 
residues that are potential N-glycosylation  sites  (NXT/S). 
The Relationship of a9 to Other Integrin c~ Subunits 
Comparison  of cx9 to  the  general  structure  of integrin  o~ 
subunits is indicated in Fig. 3 A. The consensus structure in- 
cludes:  a large NH~ terminal extracellular domain contain- 
ing seven conserved repeats (four partial and three complete 
putative metal binding domains) and in some cases the I do- 
main, an insertion of approximately 200 amino acids, a sin- 
gle transmembrane-spanning  domain,  and a  short COOH- 
terminal  cytoplasmic  domain.  Some  subunits  are  cleaved 
into two disulfide-linked fragments near the transmembrane 
domain (18). c¢9 contains the seven conserved repeats found 
in all known integrin cz subunits,  c~9 does not contain an I 
domain nor is it cleaved.  The cytoplasmic domain of oz9, as 
with all ot subunits, contains the highly conserved sequence 
GFF(R/K)R. 
Sequence,  structural,  and  functional  relationships  be- 
tween the integrin ~  subunits are shown in Fig. 3 B. The inte- 
grin a  subunit family has three distinct subfamilies. The first 
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Figure 3.  Comparison of c~9 to other human integrin a  subunits. 
(,4) The predicted structure of c~9 is shown schematically  compared 
to the consensus structure of c~ subunits, with the NHz-termini  on 
the left.  Conserved sequence repeats are indicated by black boxes 
numbered 1-7. The three conserved repeats that represent complete 
putative metal binding domains are labeled M1-M3. The I domain 
present in some subunits is indicated between conserved repeats 2 
and 3. The cleavage site present in some subunits is indicated near 
the transmembrane domain by S-S. The transmembrane domain is 
indicated  with TM.  (B) The sequence similarity  between all the 
previously reported human integrin a  subunits is indicated by tree 
diagram (reference 21).  The percent amino acid identity between 
c~9 and each human integrin c~ subunit for which the sequence has 
been published  in indicated  parenthetically  next to that subunit. 
Three  subfamilies  can be differentiated  based on structural  and 
functional  features that correlate  with sequence homologies:  (a) 
subunits which are cleaved into two disulfide-linked  fragments are 
involved in binding to the long arm of laminin or binding to RGD 
sequences present in certain extracellular matrix proteins,  (b) sub- 
units which contain the I domain are involved in binding to collagen 
and the cross region of laminin or to IgG superfamily members, and 
(c) other subunits (a4 and c~9) which neither exhibit the conserved 
cleavage  pattern nor contain the I domain. 
age near the transmembrane domain. The second subfamily 
includes the five oz subunits that contain an I domain.  The 
third subfamily consists of or4, which contains neither the I 
domain  nor  undergoes  cleavage  yielding  disulfide-linked 
fragments.  The deduced partial amino acid sequence of oD 
is  39%  identical  to the  integrin  or4 subunit  sequence  and 
18-22%  identical  to  the  other  known  human  integrin  o~ 
subunit  sequences.  Based  on  its  sequence  and  structural 
similarity to oz4, a9 is clearly a member of the third integrin 
cx subunit subfamily. 
Fig. 4 shows the alignment of the predicted cz9 amino acid 
sequence with c~4. All 23 cysteine residues found in oz9 align 
with those found in oz4 (o~4 contains one additional cysteine), 
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Figure 4. Alignment of c~9 with its closest integrin a  subunit rela- 
tive,  c~4. The deduced amino acid sequences of human c~9 and 
guinea pig c~A (reference 13) and the previously reported sequence 
of the mature form of c~4 (reference 46) are shown aligned using 
the one-letter amino acid code. Cysteine residues conserved be- 
tween a9 and c~4 are indicated by an asterisk (*). The conserved 
metal binding repeats common to all integrin c~ subunits are under- 
lined. The predicted transmembrane domains are indicated by dou- 
ble underline. The cleavage site in c~4 (++), between Arg558 and 
Ser559, is not present in a9. 
including the 19 cysteines generally found in integrin ot sub- 
units. ,4 contains a cleavage site following Lys557-Arg558 
which is absent in o~9. 
~9 Is Expressed by Teratoma and Colon Carcinoma 
Cells and Forms a Heterodimer with [31 
To demonstrate expression of or9 mRNA and to identify cell 
lines that express otg, Northern blots were performed. Total 
RNA was isolated from a variety of cell lines and analyzed 
by Northern blotting with a 2.1-kb a9 eDNA probe (Fig. 5). 
This probe hybridized with an ,~7.0-kb  mRNA band (size 
markers not shown) that was present in two of the cell lines 
tested, i.e., Tera-2, and Caco-2 cells (lanes 1 and 2).  The 
smaller band may represent partially degraded a9 mRNA. 
Alternatively, a second or9 mRNA species derived by alter- 
native splicing or an alternative polyadenylation signal may 
be present in these cells. Tera-2 cells are derived from an em- 
bryonal carcinoma,  and  Caco-2 cells from a  colon carci- 
Figure 5.  Identification of or9 
mRNA by Northern blot anal- 
ysis.  Total RNA  (30-40 #g/ 
lane)  isolated  from  human 
cell  lines  Caco-2  (lane  1), 
Tera-2 (lane 2),  HeLa (lane 
3),  Raji  (lane  4),  HuT  78 
(lane 5),  MOLT-4 (lane  6), 
and  HL-60  (lane  7)  was 
probed  for c~9 mRNA using 
2.1  kb  of  riP-labelled  c~9 
eDNA.  The positions  of the 
28- and 18-S ribosomal bands 
are indicated on the left. 
allb  KVGFFKRNRPOkEEODE£G£ 
aM  KLGFFKRQYKDNMS£GGPPGAEPQ 
aL  KVGFFKRNLKEKNEAGRGYPNGIPA~OSEQLASGQ£AGDPGCLKPLHEKOSESGGGKO 
KVGFFKRQYKEWHEEANGQ[APENGTQTPSPpSEK 
Q  RNGFFKRVRPPQEEQEREQLQPHEN~EGNSET 
KLGFFIRKYEKNTKNPDEIOETT[LS$ 
aC~L  T  KCGFFKRARTRALYEAKRQKAENKS~PSETERLTOOY 
RCGFFKRTRYYRINPKYHAVRZREEERYPPPGSTLPTKKHWVTSg~IRDRYY 
a5  [LGFFKRSLPYGTANEKAQLKPPATSDA 
a~L  T  gCGFFKRHKKDHYOATYHKAEIHAQPSDKERLTSOA 
KCGFFKRSRYDDSVPRYflAVRIRKEEREIKDEKYZONLEKKQWZTKWNRNESYS 
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Figure 6.  Alignment of integrin c¢ suhunit cytoplasmic domains. 
The COOH-terminal cytoplasmic sequences of the known human 
integrin c~ subunits are shown (references 2, 5, 9,  10, 28, 33, 39, 
42-45). The amino acid sequence of the peptide used for produc- 
tion of otg-specific rabbit antiserum is underlined and labeled a9 
Peptide. 
noma. The carcinoma-derived cell line HeLa 0ane 3) and the 
leukocyte-derived  cell lines Raji, HuT 78, MOLT-4, and HL- 
60 (lanes 4--7) were negative for expression of or9, as were 
cell lines U937 (histiocytic lymphoma), K-562 (chronic my- 
elogenous leukemia), Daudi (Burkitt's lymphoma), AN3CA 
(endometrial  carcinoma),  and  JEG-3  (choriocarcinoma) 
(data not shown). 
The sequences of the cytoplasmic domains of the known 
vertebrate integrin o~ subunits are shown in Fig. 6. It is evi- 
dent that the or9 cytoplasmic domain is distinct from all other 
subunits, except for very limited similarity to the c~4 cyto- 
plasmic domain. A 15-amino acid oL9 peptide (underlined in 
Fig.  6) with an additional cysteine residue at the NH2 ter- 
minus  was  used  to  generate polyclonal rabbit  antiserum 
which was subsequently affinity purified on the same peptide 
coupled to Sepharose. The sequence of this peptide is dis- 
tinct from the cytoplasmic domain sequences of the other a 
subunits, except for a three-amino acid identity (DSW) with 
or4. Cross-reactivity of  the anti-or9 peptide serum with or4 or 
any other known ot subunit is unlikely. 
Immunoprecipitations were performed on surface labeled 
Tera-2 lysate with a9 antiserum or with a MAb against the 
integrin [31 subunit. The immunoprecipitates were analyzed 
by SDS-PAGE under reducing and nonreducing conditions 
(Fig.  7).  Immunoprecipitation with anti-B1  yielded major 
Figure  7.  Immunoprecipi- 
tation of oD- and/~l-contain- 
ing integrins from lysates of 
Tera-2 cells. Aliquots of 125I- 
surface-labeled  lysates  from 
Tera-2 cells were immunopre- 
cipitated  with  a  monoclonal 
anti-ill  antibody (lanes 1 and 
4), affinity  purified polyclonal 
antiserum  raised  against  a 
portion of  the cytoplasmic do- 
main of a9 (lanes 2 and 5), 
and preimmune serum (lanes 
3 and 6). The proteins were 
analyzed by SDS-PAGE  under 
nonreducing (lanes 1-3)  and 
reducing (lanes 4-6) conditions followed by autoradiography. The 
positions of molecular size markers (in kD) are shown to the right• 
10-fold less lysate was used in the B1 immunoprecipitation than in 
the cO or preimmune serum immunoprecipitations. 
Palmer et al. Integrin  ~9 Subunit  Sequence and Distribution  1293 Figure 8. Immunodepletion  of 
/~1 containing integrins. Ali- 
quots of  125I-surface-labeled 
lysates from Tera-2 cells were 
subjected to  four  rounds of 
immunoprecipitation with an 
anti-/~l monoelonal antibody 
or  an  anti-/~6 mAb  cross- 
linked  to  protein  A-Sepha- 
rose.  The resulting superna- 
tants  were immunoprecipi- 
tated with affinity  purified tx9 
polyclonal  antiserum.  The 
immunoprecipitated material 
(anti-/31 first round immuno- 
precipitate,  lane  1;  anti-/31 
followed by  a9  antiserum, 
lane 2; anti-B6  followed  by tx9 antiserum, lane 3) was analyzed by 
SDS-PAGE under nonreducing conditions followed  by autoradiog- 
raphy. The positions of molecular size markers (in kD) are shown 
to the right. 
nonreduced bands at 140 and 115 kD and a minor band at 
180 kD (lane/).  These bands changed upon reduction to 
190, 150, and 130 kD (lane 4),.ot9 antiserum immunoprecip- 
itated a heterodimer consisting of 140 and 115 kD subunits 
nonreduced (lane 2) and 150 andl30 kD subunits reduced 
(lane 5). The upper band migrated with the same apparent 
molecular mass as several other previously reported integrin 
tx subunits (19). The lower band migrated with the same ap- 
parent molecular mass as/31  (19). The band present in c~9 
immunoprecipitations at  110  kD  is  also  present  in  im- 
munoprecipitations using preimmune serum (lanes 3 and 6), 
and hence is nonspecific. 
To determine if/51 was a/3 subunit partner for or9, Tera-2 
lysates were subjected to four rounds of immunodepletion 
with either anti-Bl or anti-/56 antibody followed by immuno- 
precipitation with affinity  purified o~9 antiserum. The results 
(Fig. 8) show that o~9 could not be immunoprecipitated from 
lysate depleted of/51  (lane 2).  Immunodepletion with the 
anti-/56 antibody (lane 3) did not interfere with subsequent 
precipitation of  o~9, demonstrating that nonspecific loss of o~9 
does not occur during multiple rounds of immunodeplefion. 
These results suggest that/51 is the predominant/3 subunit 
partner for ct9 in Tera-2 cells. This justifies our terminology, 
following the convention of sequentially numbering the tx 
subunit partners of/51. 
~9 Is Widely Distributed in Normal Tissues 
Because or9 was initially isolated from airway epithelial cell 
eDNA, we attempted to identify a9 in human airway tissue 
by immunohistochemistry. Fig. 9 A, shows a human airway 
biopsy section, including epithelium and submucosa, stained 
with hematoxylin, or9 antiserum intensely stained the airway 
epithelium (B). When the antiserum was incubated with oD 
peptide prior to tissue staining, staining of the epithelium 
was substantially blocked (C). 
Because we were able to detect •9  immunoreactivity in 
airway tissue, we examined the expression of oO in other tis- 
sues. Sections of mouse tissue were stained with hematoxy- 
lin (Fig. 9, D, G, and J) oO antiserum (E, H, and K), or c~9 
antiserum preblocked with o6) peptide (F, I, and L). In mouse 
esophagus (D-F), the basal layer of the epithelium (arrow) 
was stained by -9 antiserum. Skeletal muscle (M) present 
in this section also showed oD immunoreactivity. In mouse 
small intestine (G-l) both the longitudinal and circumferen- 
tial smooth muscle layers (SM) reacted with the oD antise- 
rum. Hepatocytes in the liver (J, K, and L) demonstrate cell 
surface localiTation  of ¢x9. A variety of other mouse tissues 
were analyzed for the presence of oO. Table I summarizes 
these results. The tracheal epithelium; basal epithelium of 
the larynx, pharynx, esophagus, skin, and cornea; smooth 
muscle of trachea, veins, duodenum, colon, stomach, and 
esophagus; skeletal muscle; hepatocytes; and splenic giant 
cells all demonstrated or9 immunoreactivity. In all of these 
cases, staining was blocked by incubation of the o~9 antise- 
nun with ,9 peptide prior to tissue staining. 
Discussion 
This report presents three novel findings. First, we present 
the complete amino acid sequence, deduced from eDNA and 
amino terminal sequencing, of a new member of the human 
integrin o~ suhunit family, ¢x9. Second, we demonstrate that 
oD forms an integfin heterodimer with the known [3 subunit, 
/31. Third, we show that oD is expressed in a variety of cell 
types in vivo including airway epithelial cells,  the basal 
layers  of squamous  epithelium,  smooth muscle,  skeletal 
muscle, and hepatocytes. 
Comparison of the deduced amino acid sequence of oD 
with the previously published sequences of human integrin 
ot subunits clearly demonstrates that this protein is a member 
of the integrin ¢x subunit family, or9 has high sequence ho- 
mology with other human integrin ¢x subunits and has pre- 
dicted structural features common to the intcgrin ot subunits 
including (a) a large extracellular domain containing four 
partial and three complete metal binding domains, 19 con- 
sensus cysteine residues, and several potential N-glycosyla- 
tion sites, (b) a single transmembrane spanning domain, and 
(c)  a  short  cytoplasmic domain containing the  sequence 
GFF(K/R)R.  Although oD  is  the only human integrin ot 
subunit to have the alternative sequence GFFRR, chicken or3 
contains GFFRR (22).  Both variations of this sequence are 
also found in the DNA binding domain of the members of 
the steroid hormone receptor superfamily (29).  The func- 
tional significance of this sequence is not known, although 
it has been reported that a GFFKR-containing peptide can 
interact with the Ro/SS-A  antigen (calreticulin) (35). 
There are reports  of four other integrin, subunits for 
which the human sequence has not been published. We do 
not believe that any of these four are identical to the subunit 
we describe based on the following evidence. The integrin 
subunits or7 and oL8 have been cloned from other species, and 
Figure 9. Immunohistochemical  localization  of oD. Frozen sections of human airway biopsies (A-C) and mouse esophagus (D-F), duode- 
num (G-I), and liver (J-L) were stained with hematoxylin  (A, D, G, J), with c~9 antiserum (B, E, H, K), or with oO antiserum preincubated 
with c~9 peptide ((7, F, I, L). The c~9 antiserum specifically stained airway epithelium, esophageal skeletal muscle (M) and basal cells 
of the squamous epithelium (arrow), duodenal smooth muscle (SM), and hepatocytes. 
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in Mouse  Tissue 
Tissue  oO expression  Distribution 
Trachea  + 
Larynx  + 
Esophagus  + 
Skeletal muscle  + 
Stomach  + 
Duodenum  + 
Skin  + 
Cornea  + 
Veins 
Aorta 
Pancreas  + 
Liver 
Heart  + 
Spleen 
Epithelium, smooth muscle 
Basal epithelium 







Giant cells only (rare) 
the resulting sequences have less than 21% amino acid iden- 
tity to or9 (4,  38).  Partial eDNA sequences of the human 
homologs of a7 and t~8 are clearly distinct from the or9 se- 
quence (our unpublished observations). Both of the subunits 
of a novel integrin expressed on activated leukocytes, termed 
the leukocyte response integrin, have different electropho- 
retie mobilities than does c~9 (16). The previously identified 
HML-1 antigen is an integrin composed of a novel ot subunit, 
oriEL, paired with/5'/(7, 25, 47). The HML-1 antigen has 
been detected in intraepithelial lymphocytes and a subset of 
lymphocytes located in the submucosal layer of the intestine 
(8), whereas ct9 was not detected in either the intestinal epi- 
thelial layer or submucosa. 
We screened several cell lines by Northern blotting for ex- 
pression of or9 and identified  two cell lines, Tera-2 and Caco- 
2, that expressed significant levels of ct9 mRNA. Immuno- 
precipitation  of  lysates  from  these  cell  lines  with  ct9 
anti-peptide antiserum precipitated a heterodimer consist- 
ing of a larger subunit of similar size to many other u  sub- 
units and a smaller subunit that eomigrated with/31 (Caco-2 
data not shown). Immunodepletion of/31 from Tera-2 lysates 
removed all detectable et9 irnmunoreactivity, suggesting that 
/31 is the principal/3 subunit partner for or9 in these cells. 
This increases the number of ot subunits known to associate 
with/~1 to 10. Three of these ct subunits (c~v, et4, and ct6) 
can also form heterodimers with other/3 subunits. We cannot 
exclude the possibility that or9 is expressed in low abundance 
with another/3 subunit in Tera-2 cells or that c~9 has other 
/3 subunit partners in other cell lines or in vivo. 
The closest known relative of the c~9 subunit is the c~4 
subunit, or9 and et4 share 39 % amino acid identity and are 
both equally divergent from the other known c¢ subunits. 
Consistent with their similarity, c~9, like or4, is not composed 
of two disulfide-linked fragments and does not contain an I 
domain.  Integrin  ot  subunits  generally  demonstrate  low 
correlation of sequence similarity with tissue distribution. 
Therefore, even though a9 and et4 are closely related, we 
would not necessarily expect them to have similar expression 
patterns. ~4 was first identified on leukocytes (19) and has 
more recently been shown to be expressed on endothelial 
cells (31) and in developing, but not adult, skeletal muscle 
(36).  In  contrast,  ~9  was  detected in  adult skeletal and 
smooth muscle and in a subset of epithelial cells and is not 
generally expressed in lymphocytes or in endothelium. Al- 
though or9 was detected by PCR in two leukocyte cell lines, 
it could not be detected by Northern blotting in these ceils. 
The overwhelming majority of lymphocytes present in sec- 
tions of mouse spleen did not stain with the a9 antibody. 
However,  rare,  splenic giant cells did demonstrate or9 im- 
munoreactivity, suggesting that a9 may be expressed in at 
least some leukocytes in vivo. 
Our results show widespread expression of or9 in vivo. In 
airway epithelium and the basal layer of squarnous epithe- 
lium, a9 appears to be distributed at cell-cell borders as well 
as at cellular contacts with basement membrane. In smooth 
muscle, skeletal muscle, and hepatocytes, oD appears to be 
uniformly distributed over the cell surface. In these tissues, 
a9 is expressed diffusely at sites of homotypic cell to cell 
contact in ceils that are not actively involved in spreading, 
migration, or any other obvious dynamic interaction with the 
extraceUular matrix. These results suggest that or9 may be in- 
volved in homotypic cell-ceil interactions. Although inte- 
grins are not generally thought to be involved in homotypic 
cell-cell  adhesion  in  non-leukocyte ceils,  localization of 
integrins to cell-cell contacts has been shown for c~2fll in 
bronchial epithelial cells (1), cultured keratinocytes (6), and 
endothelial ceils (27); for t~3/31 in bronchial epithelial cells 
(1), cultured keratinocytes (6), and a variety of transformed 
cell lines (24);  and for ot5/31 in endothelial cells (27).  Fur- 
thermore, contacts between cultured keratinocytes have been 
shown to be disrupted by antibodies directed against ot3/31 
and 131 (6). Mediation of cellular cohesion by integrins could 
result from direct binding of integrins to counter-receptors 
present on adjacent cells or by neighboring cells jointly bind- 
ing to extracellular matrix proteins deposited in the intercel- 
lular space. 
The results of this study demonstrate the existence of a 
previously unrecognized member of the integrin family that 
is widely expressed in vivo in differentiated cells that are not 
actively involved in migration, proliferation, or heterotypic 
interactions with other cells. These data suggest that this 
integrin may function in some aspect of normal tissue cohe- 
sion or homeostasis. More definitive functional character- 
ization will require identification of the ligand or ligands for 
this  receptor  and  the  development of reagents  that  spe- 
cifically interfere with its function. 
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